Details
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
General Intuition $220M UndisclosedStoke Space Technologies $1B Series E initial closingRecent funding activity in US startups, organised by investor and their role in each round.
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
General Intuition $220M UndisclosedStoke Space Technologies $1B Series E initial closingNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Reco $55M Series B extensionBigHat Biosciences $75M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Hertha Metals $133.7M Series A38 Degrees North $260M Credit facilityNew companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
Hertha Metals $133.7M Series AEfficient Computer >$97M Series B financing agreementsNew companies 0 · Follow-on 2
Stages: Series B 2
Efficient Computer >$97M Series B financing agreementsGimlet Labs $300M Series BNew companies 2 · Follow-on 0
Stages: Series C+ 2
SiMa.ai $150M Series CThe Boring Company $3B Series DNew companies 1 · Follow-on 1
Stages: Seed 1, Series B 1
Quartermaster $140M Series B equity + debt facilityAranya $9M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
SiMa.ai $150M Series CLightfield $47M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Quartermaster $140M Series B equity + debt facility38 Degrees North $260M Credit facilityNew companies 1 · Follow-on 1
Stages: Series B 2
Outmarket AI $34.5M Series BCarputty Undisclosed Series BNew companies 2 · Follow-on 0
Stages: Series C+ 2
Precision Neuroscience $250M Series DCrusoe $3.9B Series F (initial close; anticipated total)New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Precision Neuroscience $250M Series DTeRAM $37M FundingNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Precision Neuroscience $250M Series DFab2 $500M Series ANew companies 2 · Follow-on 0
Stages: Series C+ 2
Precision Neuroscience $250M Series DEncoded Therapeutics Inc. $275M Series FNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
BigHat Biosciences $75M Series CRegCell, Inc. $44M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
BigHat Biosciences $75M Series CN-Power Medicine $32M Series BNew companies 1 · Follow-on 1
Stages: Series C+ 2
Precision Neuroscience $250M Series DCrusoe $3.9B Series F (initial close; anticipated total)New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Silk $45M Growth capital facilityInspiren $70M Series CNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Mojave Energy Systems $19M Series BRavel $8.2M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Mojave Energy Systems $19M Series BKastle $24M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Basalt Health $20M Series AThyme Care >$125M Series ENew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Enveda $311M Series EMedici Brands $250M Series BNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Tempo Therapeutics ≤$2.3M NCI SBIR grantMolecular Targeting Technologies, Inc. $3.2M National Cancer Institute R01 grantNew companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Topdog $2.5M SeedNex >$150M Series E and new credit facility“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.